Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Effectiveness of T-DXd Across HER2-positive Solid Tumors in Patients Who Have Received Prior Systemic Treatment and Have no Satisfactory Alternative Treatment Options: A Hybrid Observational Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07124000
Title field or adapter rule
{'original_value': 'Effectiveness of T-DXd Across HER2-positive Solid Tumors in Patients Who Have Received Prior Systemic Treatment and Have no Satisfactory Alternative Treatment Options: A Hybrid Observational Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:24.992231+00:00
Published At
2026-09-25T00:00:00+00:00
Record Updated At
2026-09-25
Source Retrieved At
2026-10-31T22:17:54.613222+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adenocarcinoma (NOS)", "Anal Cancer", "Bladder Cancer", "Cervical Cancer", "Endometrial Cancer", "Esophageal Cancer", "Gall Bladder Cancer", "Gastrointestinal Stromal Tumour", "Head and Neck Cancer", "Liver Cancer", "Melanoma", "Mouth Cancer", "Nasopharangeal Cancer", "Neuroendocrine, Gastrointestinal Cancer", "Ovarian Cancer", "Pancreatic Cancer", "Prostate Cancer", "Renal Cell Carcinoma", "Salivary Gland Cancer", "Sarcoma", "Small Cell Lung Cancer", "Testicular Cancer", "Throat Cancer", "Thyroid Cancer", "Urethral Cancer", "Vaginal Cancer", "Vulvar Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-09-25", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07124000"
protocolSection.identificationModule.officialTitle
"Effectiveness of T-DXd Across HER2-positive Solid Tumors in Patients Who Have Received Prior Systemic Treatment and Have no Satisfactory Alternative Treatment Options: A Hybrid Observational Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
null
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Adenocarcinoma (NOS) (protocolSection.conditionsModule.conditions)
  • Anal Cancer (protocolSection.conditionsModule.conditions)
  • Bladder Cancer (protocolSection.conditionsModule.conditions)
  • Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Endometrial Cancer (protocolSection.conditionsModule.conditions)
  • Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Gall Bladder Cancer (protocolSection.conditionsModule.conditions)
  • Gastrointestinal Stromal Tumour (protocolSection.conditionsModule.conditions)
  • Head and Neck Cancer (protocolSection.conditionsModule.conditions)
  • Liver Cancer (protocolSection.conditionsModule.conditions)
  • Melanoma (protocolSection.conditionsModule.conditions)
  • Mouth Cancer (protocolSection.conditionsModule.conditions)
  • Nasopharangeal Cancer (protocolSection.conditionsModule.conditions)
  • Neuroendocrine, Gastrointestinal Cancer (protocolSection.conditionsModule.conditions)
  • Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Salivary Gland Cancer (protocolSection.conditionsModule.conditions)
  • Sarcoma (protocolSection.conditionsModule.conditions)
  • Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Testicular Cancer (protocolSection.conditionsModule.conditions)
  • Throat Cancer (protocolSection.conditionsModule.conditions)
  • Thyroid Cancer (protocolSection.conditionsModule.conditions)
  • Urethral Cancer (protocolSection.conditionsModule.conditions)
  • Vaginal Cancer (protocolSection.conditionsModule.conditions)
  • Vulvar Cancer (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Trastuzumab deruxtecan'], 'description': 'Trastuzumab deruxtecan monotherapy', 'name': 'Trastuzumab deruxtecan', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Trastuzumab deruxtecan (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.